Please ensure Javascript is enabled for purposes of website accessibility

Is Nano-X a Buy?

By Taylor Carmichael - Mar 11, 2021 at 6:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This healthcare disrupter is about to receive FDA clearance to start distributing its new X-ray device.

Nano-X Imaging (NNOX 3.59%) hit the public markets last year at $20 a share. The stock quickly shot up to over $60, and then crashed back down to $24, then ran up to $86. Now the share price sits at $39. Is Nano-X a buy today? In this video clip from Motley Fool Live, recorded live on March 5, Corinne Cardina, bureau chief of healthcare and cannabis at, and Motley Fool contributor Taylor Carmichael discuss the upside of Nano-X.

Corinne Cardina: Let's talk about Nano-X.

Taylor Carmichael: Okay.

Cardina: Could you tell us what that company is and maybe briefly one green flag and one red flag for this stock.

Carmichael: Nano-X is an Israeli company, they have a new kind of X-ray, which is amazing device. X-rays are kind of boring. They've been around for over a 100 years. They are very expensive devices, CAT scans, MRI devices that costs about a million, 2 million, 3 million dollars, hospitals buy them and they are expensive. You can wait a long time sometimes to get it scheduled. Nano-X has made a radical new discovery. What your traditional X-ray device, your MRI, your CAT scan needs to do to create the X-ray is to heat the machine up to, I might get this number wrong. It's over 1,000 degrees Fahrenheit, might be 2,000 degrees Fahrenheit. It is incredibly hot machine and then it has to cool it down, which is where all the expense is. What Nano-X has discovered is a way to do that using nanotechnology to create the X-ray without having to manufacture all this heat and cool the machine down. It's a far cheaper machine. It's a far cheaper X-ray machine, $10,000 instead of a million. That's a couple of degrees magnitude cheaper. I believe they're not only going to radically disrupt the market, they are also going to expand the market. You're going to see a lot more X-rays. It's also a software-as-a-service company because what I love about this company, they're going to get paid every time it's used. They are basically going to give the machine away for $10,000 or less, but every time it's used, they're going to take a slice off of every X-ray, and they've got that huge recurring revenue model, which is brilliant for Intuitive Surgical investors or investors who love that razor/blades model. But that's a wonderful thing. I'm very excited about Nano-X. The device is not on the market yet. They're waiting for FDA, approval is not the word, what's the other word that we say?

Cardina: Clearance for the device.

Carmichael: Clearance, they're waiting for clearance and they should have it within a month.

Cardina: Awesome, and they just reported earnings. It was very impressive. I don't want to go into it, so we have time to go to the next one, but take a look.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Nano-X Imaging Ltd. Stock Quote
Nano-X Imaging Ltd.
$9.52 (3.59%) $0.33

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.